GRAIL, LLC's stock has taken a significant hit amid growing concerns about its financial performance compared to competitors.
GRAIL, LLC (NASDAQ:GRAL) experienced a notable decline in its stock price today, dropping by 3.42% to close at CA$135.77. This downturn comes as investors weigh the company's financial metrics against its competitors in the cancer diagnostics space.
Advertisement
GRAIL, LLC
GRAL.US
GRAL.US
GRAIL, LLC
WealthAwesomeMarket cap
$6.28B
52W high
$166.47
52W low
$41.50
1W change
-1.87%
Beta
2.84
Analyst Price Targets
Based on 11 analysts covering GRAL · as of Oct 12, 2026
Wall Street analysts forecast GRAL stock price to fall 17.4% over the next 12 months.
Consensus
Buy3.91 / 5.00
Avg. Target
C$116.10
-17.4% Upside
Current Price
C$140.58
Last close
Analyst Breakdown (11 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on GRAL's historical volatility
30-Day Vol
109.3%
Annualized
90-Day Vol
89.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$168.06
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$149.20 | C$102.33 – C$217.54 |
| 60 trading days | C$158.35 | C$92.90 – C$269.91 |
| 90 trading days | C$168.06 | C$87.47 – C$322.94 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should remain cautious about GRAIL's financial health, particularly its negative operating margins and the stark revenue gap compared to Guardant Health.
Operating Margin at GRAIL is a Staggering -332.00%
GRAIL's operating margin highlights the urgent need for the company to improve its cost structure and revenue generation to attract investor confidence.
Bull case
Despite the current downturn, GRAIL has a strong cash position. This could provide a buffer for future growth and development if the company can enhance its revenue generation.
Bear case
The significant operating loss of 332.00% raises serious concerns about GRAIL's business model, especially when compared to the more successful Guardant Health, which has a much healthier revenue stream.
Advertisement
Financial Performance Under Scrutiny
GRAIL's recent performance has raised eyebrows, particularly with its staggering operating margin of -332.00%. This figure starkly contrasts with Guardant Health, which has successfully maintained a negative operating margin of only -38.25%. The revenue gap is also alarming, with Guardant Health generating $1.18 billion compared to GRAIL's mere $165.26 million. Such disparities are prompting investors to reconsider their positions in GRAIL.
Market Sentiment and Hedge Fund Activity
As of the end of Q2 2026, GRAIL was held by 29 hedge funds with a combined stake value of about $1.06 billion, a decrease from the previous quarter. This decline in hedge fund interest suggests a growing skepticism around GRAIL's ability to turn its financial situation around, especially in light of its ongoing cash burn and the competitive landscape it faces against companies like Guardant Health.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
